Research has suggested that PSP may serve as a prophylactic and therapeutic agent against colorectal cancer (CRC) by down-regulating the programmed cell-death ligand 1 (PD-L1) and epidermal growth factor receptor (EGFR) signaling pathways [11]. This evidence concerns the gene EGFR and colorectal carcinoma.